0002064953-25-000018
SEC filingNet sales grew 7% YoY to $969M, but gross margin contracted to 32% from 37%, and net income swung to a $(9)M loss due to $32M transaction costs and a 105% effective tax rate.
In Q3 2025, net sales increased 7% YoY to $969M, driven by higher sales volume (2%), favorable pricing (3%), and currency translation (2%). Volume growth was led by refrigerants, partially offset by declines in healthcare packaging. Gross profit fell 7% to $310M, with gross margin contracting 500bps to 32%, reflecting increased cost of products sold (up 15%) due to volume and product mix. Operating income (calculated as gross profit minus R&D, SG&A, and transaction costs) was $139M, down 31% from $201M in the prior year, yielding an operating margin of 14.3% (vs 22.2%). Net income swung to a loss of $9M from a profit of $148M, primarily due to $32M in transaction-related costs, a $37M swing in other income (driven by a government reimbursement of legal expenses), and a 105% effective tax rate (vs 25%) resulting from frictional tax costs related to the spin-off.
The RAS segment posted a 9% revenue increase to $687M, driven by favorable pricing and volume growth in refrigerants; however, Segment Adjusted EBITDA decreased 3% to $243M and margin contracted 430bps to 35.4%, attributed to product mix effects from the ongoing transition to low-GWP refrigerants. The ESM segment saw a 2% revenue increase to $282M, with volume gains in safety/defense and electronic materials partially offset by declines in research chemicals. Segment Adjusted EBITDA fell 15% to $47M and margin dropped 320bps to 16.7%, driven by anticipated transitory cost items. Corporate and All Other costs increased 64% to $21M due to incremental ongoing costs of operating as a standalone company.
Management expects transaction-related costs to continue through at least fiscal year 2026, along with higher ongoing costs as an independent public company. No specific quantitative guidance was provided, but the company believes existing cash, operating cash flows, and available credit facilities (including $1.0B senior notes and $1.0B revolving credit facility) are sufficient for at least the next 12 months. The spin-off from Honeywell was consummated on October 30, 2025, and the company's future results may differ materially from historical combined results. Mitigation strategies for macroeconomic conditions (tariffs, supply chain) remain a priority, but no material impact on product quality or reliability is expected.
As of September 30, 2025, Solstice Advanced Materials reported cash and cash equivalents of $417M, down from $661M at year-end 2024, driven by $310M in net transfers to Parent. Total assets were $5.247B, with inventory rising to $732M (from $558M) and accounts receivable increasing to $635M. The company had no long-term debt on its balance sheet, but finance lease liabilities totaled $121M. Subsequent to quarter-end, the company issued $1.0B in 5.625% Senior Notes due 2033 and entered into a $1.0B Term Loan Facility, with proceeds used primarily for a $1.5B distribution to Honeywell upon spin-off completion on October 30, 2025.
Remaining performance obligations (RPO) stood at $2,866M as of September 30, 2025, with 36% expected to be satisfied within one year and 64% beyond. The company also maintained supply chain financing programs with $111M included in accounts payable. Additionally, product loans receivable and payable of $274M each were recorded at fair value, related to uranium ore lending arrangements. Environmental liabilities were $53M, and asset retirement obligations for decommissioning the uranium conversion facility were also recognized.
No share buybacks or dividends were reported for the period. Capital expenditures totaled $248M for the nine months, with $150M in Refrigerants & Applied Solutions and $98M in Electronic & Specialty Materials. Post-period, the company's debt issuance and term loan facility significantly increased leverage, with the proceeds used to fund the spin-off distribution and fees.
Segment revenue for the nine months ended September 30, 2025: Refrigerants & Applied Solutions $2,079M (up 0.2% YoY) and Electronic & Specialty Materials $820M (up 4.9% YoY). Segment adjusted EBITDA was $791M and $152M, respectively. Geographic mix was not disclosed in the notes.
Net income for the nine months ended September 30, 2025 was $231M, while operating cash flow (CFO) was $289M, resulting in a CFO-to-net income ratio of 1.25, indicating solid cash generation. However, CFO declined sharply from $567M in the prior period, driven by significant working capital outflows: accounts receivable increased by $46M (vs. a decrease of $18M last year), inventories rose by $150M (vs. a $4M increase), and accounts payable improved by $82M (vs. a $35M decline). These swings suggest operational challenges or strategic inventory building. Capital expenditures (capex) increased to $248M, representing 86% of CFO, up from 35% in the prior period, reflecting heavy investment in fixed assets. The resulting free cash flow (not explicitly stated) would be negative given CFO of $289M and capex of $248M. Financing activities were dominated by $310M in net transfers to parent, partially offset by $18M in finance lease payments. Overall, cash and equivalents decreased by $244M from $661M to $417M. The decline in operating cash flow and high capex intensity raise concerns about near-term cash sustainability, though the spin-off may alter future capital allocation.